LAWRENCE J STEINMAN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for LAWRENCE J STEINMAN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of LAWRENCE J STEINMAN. LAWRENCE J STEINMAN is a Director in Atreca, Inc. ($BCEL) and a Director in 180 Life Sciences Corp. ($KBLM) and a Director in BioAtla, Inc. ($BCAB).

Companies in which LAWRENCE J STEINMAN is an Insider

180 Life Sciences Corp.

Trading Symbol: KBLM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LAWRENCE J STEINMAN: Director
Holdings: 592,358 shares
Latest Transaction: Apr 08 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Atreca, Inc.

Trading Symbol: BCEL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LAWRENCE J STEINMAN: Director
Holdings: 258,405 shares
Latest Transaction: Jun 24 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BioAtla, Inc.

Trading Symbol: BCAB
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of LAWRENCE J STEINMAN: Director
Holdings: 20,259 shares
Latest Transaction: Jun 16 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of LAWRENCE J STEINMAN

Sentiment: All, KBLM, BCEL, BCAB

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 16 2021BCABBioAtla, Inc.STEINMAN LAWRENCEDirectorOption ExerciseA39.6412,307487,84912,307
Jun 16 2021BCABBioAtla, Inc.STEINMAN LAWRENCEDirectorBuyJ0.005,388020,25914.9 K to 20.3 K (+36.23 %)
Apr 08 2021KBLM180 Life Sciences ...STEINMAN LAWRENCEDirectorGrantA6.1422,585138,672592,358569.8 K to 592.4 K (+3.96 %)
Jun 24 2019BCELAtreca, Inc.STEINMAN LAWRENCEDirectorOption ExerciseC0.008,40500
Jun 24 2019BCELAtreca, Inc.STEINMAN LAWRENCEDirectorBuyC0.008,4050258,405250 K to 258.4 K (+3.36 %)

View all LAWRENCE J STEINMAN insider transactions.